MRX Investors Get Chance to Lead Securities Fraud Suit Against Marex Group plc

The Schall Law Firm has issued a notice to shareholders of Marex Group plc (NASDAQ: MRX), alerting them to a class‑action lawsuit alleging securities fraud under §§10(b) and 20(a) of the Securities Exchange Act of 1934 and SEC Rule 10b‑5. The lawsuit covers investors who purchased Marex securities between May 16, 2024 and August 5, 2025 (the “Class Period”). Those shareholders are encouraged to contact the firm before the lead‑plaintiff filing deadline on December 8, 2025. According to the complaint, Marex allegedly sold over‑the‑counter financial products to itself. Further, financial statements reportedly contained inconsistencies between subsidiaries and related parties — including intercompany receivables and loans — making the financials unreliable. These alleged practices rendered the Company’s public statements materially misleading. Investors who believe they suffered losses during the Class Period may participate in the class action; until the class is certified, they are not represented by counsel unless they retain one. #Marex #MRX #SecuritiesFraud #ClassAction #SlimScan #GrowthStocks #CANSLIM